Sociedad Americana de Hirudoterapia

Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych

URPL · Poland · europe

Regulatory jurisdiction profileJurisdictional reference
Medical device clearednational regulator

Poland's Office for Registration of Medicinal Products, Medical Devices and Biocidal Products — applies EU MDR; leech-specific regulation has not been independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Poland
Leech status
medical device cleared
Last ASH review
2026-05-25

Relevant Regulation Codes

  • Ustawa o wyrobach medycznych (Polish Medical Devices Act, 2022)
  • Regulation (EU) 2017/745 (MDR) — direct effect

Prescriber Requirements

  • Naczelna Izba Lekarska-registered MD prescription required
  • Non-physician practitioner scope for hirudotherapy not independently verified by ASH

Supply Chain & GMP

EU MDR-aligned registration with URPL; Polish-language IFU; cold chain per manufacturer specifications.

Import/Export Rules

Intra-EU free movement. Third-country imports through URPL notification and standard CITES Appendix II paperwork; Główny Inspektorat Weterynarii for live-invertebrate clearance.

Reimbursement Context

NFZ (Narodowy Fundusz Zdrowia) covers inpatient indications via hospital DRG bundling; specific outpatient hirudotherapy reimbursement status not independently verified by ASH.

ASH Editorial Notes

Poland has a substantial traditional and complementary medicine community; specific regulatory framework applicable to hirudotherapy has not been independently verified by ASH and should be reviewed by Polish counsel before relying on for compliance.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.